HRR Prevalence in LatAm PROSPECT Study

Trial Identifier: D081LR00003
Sponsor: AstraZeneca
NCTID:: NCT04962880
Start Date: April 2021
Primary Completion Date: April 2022
Study Completion Date: April 2022
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations